Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies

por Di Noia, V., D’Aveni, A., D’Argento, E., Rossi, S., Ghirardelli, P., Bortolotti, L., Vavassori, V., Bria, E., Ceresoli, G.L.
Publicado 2021

Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes

por Barbera, F, Triggiani, L, Buglione, M, Ghirardelli, P, Vitali, P, Caraffini, B, Borghetti, P, Greco, D, Bardoscia, L, Pasinetti, N, Costa, L, Maddalo, M, Ghedi, B, La Face, B, Magrini, SM
Publicado 2017